Serum CA19-9 response as a surrogate for clinical outcome in patients receiving fixed-dose rate gemcitabine for advanced pancreatic cancer (Q41963194)
Jump to navigation
Jump to search
scientific article published on July 2005
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Serum CA19-9 response as a surrogate for clinical outcome in patients receiving fixed-dose rate gemcitabine for advanced pancreatic cancer |
scientific article published on July 2005 |
Statements
1 reference
Serum CA19-9 response as a surrogate for clinical outcome in patients receiving fixed-dose rate gemcitabine for advanced pancreatic cancer (English)
1 reference
A H Ko
1 reference
J Hwang
1 reference
A P Venook
1 reference
J L Abbruzzese
1 reference
E K Bergsland
1 reference
M A Tempero
1 reference
1 reference
Identifiers
1 reference